Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.

Dosimetric benefit of a new ophthalmic radiation plaque.

Marwaha G, Wilkinson A, Bena J, Macklis R, Singh AD.

Int J Radiat Oncol Biol Phys. 2012 Dec 1;84(5):1226-30. doi: 10.1016/j.ijrobp.2012.01.084. Epub 2012 Jun 1.

PMID:
22658440
2.
3.

Dosimetry of (125)I and (103)Pd COMS eye plaques for intraocular tumors: report of Task Group 129 by the AAPM and ABS.

Chiu-Tsao ST, Astrahan MA, Finger PT, Followill DS, Meigooni AS, Melhus CS, Mourtada F, Napolitano ME, Nath R, Rivard MJ, Rogers DW, Thomson RM.

Med Phys. 2012 Oct;39(10):6161-84. doi: 10.1118/1.4749933.

4.

Lack of radiation maculopathy after palladium-103 plaque radiotherapy for iris melanoma.

Yousef YA, Finger PT.

Int J Radiat Oncol Biol Phys. 2012 Jul 15;83(4):1107-12. doi: 10.1016/j.ijrobp.2011.09.033. Epub 2011 Dec 13.

PMID:
22172910
5.

Comparison of 16 mm OSU-Nag and COMS eye plaques.

Zhang H, Davidorf F, Qi Y.

J Appl Clin Med Phys. 2012 May 10;13(3):3632. doi: 10.1120/jacmp.v13i3.3632.

PMID:
22584165
6.

Dosimetric verification of a dedicated 3D treatment planning system for episcleral plaque therapy.

Knutsen S, Hafslund R, Monge OR, Valen H, Muren LP, Rekstad BL, Krohn J, Dahl O.

Int J Radiat Oncol Biol Phys. 2001 Nov 15;51(4):1159-66.

PMID:
11704341
7.

Radiobiology for eye plaque brachytherapy and evaluation of implant duration and radionuclide choice using an objective function.

Gagne NL, Leonard KL, Rivard MJ.

Med Phys. 2012 Jun;39(6):3332-42. doi: 10.1118/1.4718683.

PMID:
22755715
8.

Novel low-kVp beamlet system for choroidal melanoma.

Esquivel C Jr, Fuller CD, Waggener RG, Wong A, Meltz M, Blough M, Eng TY, Thomas CR Jr.

Radiat Oncol. 2006 Sep 11;1:36.

9.

A five-year study of slotted eye plaque radiation therapy for choroidal melanoma: near, touching, or surrounding the optic nerve.

Finger PT, Chin KJ, Tena LB.

Ophthalmology. 2012 Feb;119(2):415-22. doi: 10.1016/j.ophtha.2011.08.017. Epub 2011 Nov 30.

PMID:
22133796
10.

125I plaque therapy for uveal melanoma. Analysis of the impact of time and dose factors on local control.

Quivey JM, Augsburger J, Snelling L, Brady LW.

Cancer. 1996 Jun 1;77(11):2356-62.

11.

Posttreatment visual acuity in patients treated with episcleral plaque therapy for choroidal melanomas: dose and dose rate effects.

Jones R, Gore E, Mieler W, Murray K, Gillin M, Albano K, Erickson B.

Int J Radiat Oncol Biol Phys. 2002 Mar 15;52(4):989-95.

PMID:
11958893
12.

Improved treatment planning for COMS eye plaques.

Astrahan MA.

Int J Radiat Oncol Biol Phys. 2005 Mar 15;61(4):1227-42.

PMID:
15752905
13.

ROPES eye plaque brachytherapy dosimetry for two models of (103)Pd seeds.

Saidi P, Sadeghi M, Shirazi A, Tenreiro C.

Australas Phys Eng Sci Med. 2011 Jun;34(2):223-31. doi: 10.1007/s13246-011-0069-1. Epub 2011 Mar 31. Erratum in: Australas Phys Eng Sci Med. 2011 Dec;34(4):641.

PMID:
21452056
14.

Iodine brachytherapy as an alternative to enucleation for large uveal melanomas.

Puusaari I, Heikkonen J, Summanen P, Tarkkanen A, Kivelä T.

Ophthalmology. 2003 Nov;110(11):2223-34.

PMID:
14597534
15.

Proliferative radiation retinopathy after plaque radiotherapy for uveal melanoma.

Bianciotto C, Shields CL, Pirondini C, Mashayekhi A, Furuta M, Shields JA.

Ophthalmology. 2010 May;117(5):1005-12. doi: 10.1016/j.ophtha.2009.10.015. Epub 2010 Jan 15.

PMID:
20079924
16.

A reanalysis of the Collaborative Ocular Melanoma Study Medium Tumor Trial eye plaque dosimetry.

Krintz AL, Hanson WF, Ibbott GS, Followill DS.

Int J Radiat Oncol Biol Phys. 2003 Jul 1;56(3):889-98.

PMID:
12788199
17.

Risk factors for neovascular glaucoma after proton beam therapy of uveal melanoma: a detailed analysis of tumor and dose-volume parameters.

Mishra KK, Daftari IK, Weinberg V, Cole T, Quivey JM, Castro JR, Phillips TL, Char DH.

Int J Radiat Oncol Biol Phys. 2013 Oct 1;87(2):330-6. doi: 10.1016/j.ijrobp.2013.05.051. Epub 2013 Jul 23.

PMID:
23886415
18.

Alternative dose for choroidal melanoma treated with an iodine-125 radioactive plaque: a single-institution retrospective study.

Saconn PA, Gee CJ, Greven CM, McCoy TP, Ekstrand KE, Greven KM.

Int J Radiat Oncol Biol Phys. 2010 Nov 1;78(3):844-8. doi: 10.1016/j.ijrobp.2009.08.059. Epub 2010 Feb 19.

PMID:
20171804
19.

Model-based dose calculations for COMS eye plaque brachytherapy using an anatomically realistic eye phantom.

Lesperance M, Inglis-Whalen M, Thomson RM.

Med Phys. 2014 Feb;41(2):021717. doi: 10.1118/1.4861715.

PMID:
24506608
20.

Monte Carlo simulation of COMS ophthalmic applicators loaded with Bebig I25.S16 seeds and comparison with planning system predictions.

Miras H, Terrón JA, Lallena AM.

Phys Med. 2013 Nov;29(6):670-6. doi: 10.1016/j.ejmp.2012.07.003. Epub 2012 Jul 31.

PMID:
22858007
Items per page

Supplemental Content

Write to the Help Desk